These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 21868542)
1. Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. Mohr SB; Gorham ED; Alcaraz JE; Kane CJ; Macera CA; Parsons JK; Wingard DL; Garland CF Anticancer Res; 2011 Sep; 31(9):2939-48. PubMed ID: 21868542 [TBL] [Abstract][Full Text] [Related]
2. Dose-response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: A meta-analysis. Garland CF; Gorham ED J Steroid Biochem Mol Biol; 2017 Apr; 168():1-8. PubMed ID: 27993551 [TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort. McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273 [TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: serum vitamin D and breast cancer risk. Yin L; Grandi N; Raum E; Haug U; Arndt V; Brenner H Eur J Cancer; 2010 Aug; 46(12):2196-205. PubMed ID: 20456946 [TBL] [Abstract][Full Text] [Related]
5. Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies. Chen P; Li M; Gu X; Liu Y; Li X; Li C; Wang Y; Xie D; Wang F; Yu C; Li J; Chen X; Chu R; Zhu J; Ou Z; Wang H PLoS One; 2013; 8(1):e49312. PubMed ID: 23382798 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Kim Y; Je Y Br J Cancer; 2014 May; 110(11):2772-84. PubMed ID: 24714744 [TBL] [Abstract][Full Text] [Related]
7. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies. Wang D; Vélez de-la-Paz OI; Zhai JX; Liu DW Tumour Biol; 2013 Dec; 34(6):3509-17. PubMed ID: 23807676 [TBL] [Abstract][Full Text] [Related]
8. Vitamin D and prevention of breast cancer: pooled analysis. Garland CF; Gorham ED; Mohr SB; Grant WB; Giovannucci EL; Lipkin M; Newmark H; Holick MF; Garland FC J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):708-11. PubMed ID: 17368188 [TBL] [Abstract][Full Text] [Related]
9. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study. Bilinski K; Boyages J Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153 [TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study. Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J Carcinogenesis; 2008 Jan; 29(1):93-9. PubMed ID: 17974532 [TBL] [Abstract][Full Text] [Related]
11. Serum 25-hydroxyvitamin D and breast cancer in the military: a case-control study utilizing pre-diagnostic serum. Mohr SB; Gorham ED; Alcaraz JE; Kane CI; Macera CA; Parsons JK; Wingard DL; Horst R; Garland CF Cancer Causes Control; 2013 Mar; 24(3):495-504. PubMed ID: 23296455 [TBL] [Abstract][Full Text] [Related]
12. Vitamin D Status and Risk of Breast Cancer in Iranian Women: A Case-Control Study. Jamshidinaeini Y; Akbari ME; Abdollahi M; Ajami M; Davoodi SH J Am Coll Nutr; 2016; 35(7):639-646. PubMed ID: 27331363 [TBL] [Abstract][Full Text] [Related]
13. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862 [TBL] [Abstract][Full Text] [Related]
14. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912 [TBL] [Abstract][Full Text] [Related]
15. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1339-43. PubMed ID: 18559548 [TBL] [Abstract][Full Text] [Related]
16. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450 [TBL] [Abstract][Full Text] [Related]
17. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years. Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324 [TBL] [Abstract][Full Text] [Related]
18. 25-hydroxyvitamin D and breast cancer, colorectal cancer, and colorectal adenomas: case-control versus nested case-control studies. Grant WB Anticancer Res; 2015 Feb; 35(2):1153-60. PubMed ID: 25667506 [TBL] [Abstract][Full Text] [Related]
19. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors? Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459 [TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Mohr SB; Gorham ED; Kim J; Hofflich H; Garland CF Anticancer Res; 2014 Mar; 34(3):1163-6. PubMed ID: 24596354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]